QT
VNDA icon

Quantamental Technologies’s Vanda Pharmaceuticals VNDA Stock Holding History

Quantamental Technologies’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,013
Closed -$146K – 1320
2019
Q3 		$146K Buy
11,013
+4,056
+58% +$56.5K 0.05% 600
2019
Q2 		$98K Sell
6,957
-1,492
-18% -$23.7K 0.04% 686
2019
Q1 		$155K Buy
+8,449
New +$193K 0.07% 460

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Quantamental Technologies's VNDA Position: Q4 2019 in Review

Quantamental Technologies sold out of Vanda Pharmaceuticals (VNDA) in Q4 2019, closing a stake of 11,013 shares — an estimated $146K sold.

Quantamental Technologies first reported a position in VNDA in Q1 2019 and held it in 3 quarters. The position peaked at $155K in Q1 2019. 179 funds tracked by Wall St. Rank hold VNDA as of Q4 2019.

  • Quantamental Technologies reported no remaining Vanda Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 11,013 Vanda Pharmaceuticals shares in Q4 2019, an estimated $146K.
  • Quantamental Technologies first reported a position in Vanda Pharmaceuticals in Q1 2019 and held it in 3 quarters.
  • Quantamental Technologies's Vanda Pharmaceuticals position peaked at $155K in Q1 2019.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.